!Kung,
How unfortunate of you to be the closest respond button.
NOTE: There is little of biotech value in the following, and if you are easily offended, I apologize and urge you not to read on...
***********************************
****************************************************
...couldn't resist could you.
OK, guys with Rman MIM (missing in Michigan) do I have to find all the juvenile humor? Another one from the department of erectile dysfunction (this part of the job is easy to get up for):
biz.yahoo.com
MacroChem Corporation announced successful results in clinical
trials of SEPA/Alprostadil in erectile dysfunction. I'm sorry, but in view of the indication shouldn't that be MINI-Chem?
From the text:
>>Each patient received a single application of gel, and erectile responses were measured over a one and one- half hour period
following dosing.<<
Single application of gel...over a one and one-half hour period?
>>Erectile scores were determined by the clinical investigator. Forty-eight patients with clinically confirmed erectile dysfunction entered and completed the study...Of patients treated with topical SEPA/alprostadil, 67 - 75% responded with erections sufficient for vaginal intercourse,<<
...entered and completed the study...erections sufficient for vaginal intercourse...determined by the clinical investigator. If the subjects were compensated for participation, I really hope this trial took place in Nevada.
>>Treatment -- induced responses began approximately 15-20 minutes after dosing, with maximal response at about 45-50 minutes.<<
Foreplay.
!Kung San, I warned you it wasn't going to be pretty...
Well guys, if I'm not here tomorrow, you'll know Jill has pulled my player's card. Rman, come home...
biowa |
